mRNA Therapeutics CDMO Market Trends, Share and Growth Analysis 2035
According to Payal Rabde, who specializes in mRNA synthesis, formulation, lipid nanoparticles, drug delivery, process development, analytical testing, GMP manufacturing scale-up, fill-finish, quality control, and mRNA therapeutics, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the mRNA therapeutics CDMO market. The global mRNA therapeutics CDMO market size was estimated at USD 5.15 billion in 2025 and is predicted to increase from USD 5.73 billion in 2026 to approximately USD 13.63 billion by 2034, expanding at a CAGR of 11.37% from 2026 to 2035. The market is growing due to rising demand for mRNA-based vaccines and therapies, increasing outsourcing by biopharma companies, and advances in scalable manufacturing and lipid nanoparticle technologies.
Last Updated : 08 September 2026
Category: Healthcare Services
Insight Code: 5831
Format: PDF / PPT / Excel